Reduced Estradiol-Induced Vasodilation and Poly-(ADP-Ribose) Polymerase (PARP) Activity in the Aortas of Rats with Experimental Polycystic Ovary Syndrome (PCOS)-Reference-Cited by-同舟云学术

Reduced Estradiol-Induced Vasodilation and Poly-(ADP-Ribose) Polymerase (PARP) Activity in the Aortas of Rats with Experimental Polycystic Ovary Syndrome (PCOS)

Published:2013-03-26 Issue:3 Volume:8 Page:e55589
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Masszi Gabriella,Horvath Eszter Maria,Tarszabo Robert,Benko Rita,Novak Agnes,Buday Anna,Tokes Anna-Maria,Nadasy Gyorgy L.,Hamar Peter,Benyó Zoltán,Varbiro Szabolcs

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference40 articles.

1. American Association of Clinical Endocrinologists (2005) Position Statement on Metabolic and Cardiovascular Consequences of Polycystic Ovary Syndrome Endocrine Practice Vol.11 No.2.

2. Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society;RA Wild;J Clin Endocrinol,2010

3. Prevalence and predictors of coronary artery calcification in women with polycystic ovary syndrome;RC Christian;J Clin Endocrinol,2003

4. Internal carotid artery haemodynamics in women with polycystic ovaries. Clin. Sci. (Lond);K Lakhani,2000

5. Predictors of endothelial dysfunction in young women with polycystic ovary syndrome. J Clin Endocrinol Metab;M Kravariti,2005

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nonhemodynamic Components of EVA: Polycystic Ovary Syndrome (PCOS);Early Vascular Aging (EVA);2024

2. Effects of Gender and Vitamin D on Vascular Reactivity of the Carotid Artery on a Testosterone-Induced PCOS Model;International Journal of Molecular Sciences;2023-11-21

3. Comprehensive Meta-Analysis of Functional and Structural Markers of Subclinical Atherosclerosis in Women with Polycystic Ovary Syndrome;Angiology;2022-03-08

4. Sex and Gender Aspects in Vascular Ageing – Focus on Epidemiology, Pathophysiology, and Outcomes;Heart, Lung and Circulation;2021-11

5. PARPs in lipid metabolism and related diseases;Progress in Lipid Research;2021-11